Trial intelligence / Profile preview

Sublingual atropine for saliva control during intraoral scanning

RBR-9zx9hy2Completed

Sponsor
Universidade Estadual de Ponta Grossa
Start
Mar 2025
Modality
Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Randomised, triple-blind trial of atropine in hypersalivation (2 arms), sponsored by Universidade Estadual de Ponta Grossa. Primary endpoint: Salivary flow. Started Mar 2025; status: completed.

02

Drugs

atropine
03

Conditions

hypersalivation

Beyond the preview

Go deeper on RBR-9zx9hy2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-9zx9hy2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call